The researchers suggested that LCN2 could act in the development of insulin resistance in GDM, and its expression in subcutaneous adipose tissue may be associated with obesity in GDM women [42]. This evidence concerns the gene LCN2 and obesity due to melanocortin 4 receptor deficiency.